Eledon Pharmaceuticals, Inc.
ELDN
$2.72
-$0.06-2.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.91% | 79.28% | -6.48% | 95.07% | -16.12% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -68.30% | 121.66% | -16.73% | -31.75% | 2.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -92.46% | 64.93% | 181.53% | 190.74% | -40.00% |
| Total Current Assets | -11.14% | 76.34% | -6.55% | 81.80% | -14.52% |
|
|
|||||
| Total Current Assets | -11.14% | 76.34% | -6.55% | 81.80% | -14.52% |
| Net Property, Plant & Equipment | -8.21% | 96.60% | -24.15% | 130.00% | -26.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.48% | 72.86% | -17.65% | 37.84% | -0.54% |
| Total Assets | -9.07% | 54.84% | -4.90% | 49.08% | -9.26% |
|
|
|||||
| Total Accounts Payable | -50.27% | -0.46% | 172.81% | 15.24% | 92.76% |
| Total Accrued Expenses | 9.74% | -15.72% | 78.58% | 71.89% | -17.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.50% | 68.82% | -30.86% | -5.28% | -25.85% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -20.66% | -7.30% | 107.29% | 41.86% | 9.04% |
|
|
|||||
| Total Current Liabilities | -20.66% | -7.30% | 107.29% | 41.86% | 9.04% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.28% | 103.17% | -18.39% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -21.38% | 82.97% | -79.02% | 34.25% | 17.11% |
| Total Liabilities | -21.15% | 53.86% | -70.14% | 35.00% | 16.72% |
|
|
|||||
| Common Stock & APIC | 0.63% | 22.43% | 1.97% | 15.58% | 0.52% |
| Retained Earnings | -1.83% | -14.35% | 19.84% | -13.09% | -7.40% |
| Treasury Stock & Other | -169.23% | -74.51% | -- | -- | -- |
| Total Common Equity | -3.01% | 55.33% | 994.69% | 42.28% | -304.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.01% | 55.33% | 994.69% | 42.28% | -304.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.01% | 55.33% | 994.69% | 42.28% | -304.33% |
|
|
|||||